MEDICETIE
0878.877.507 · rovalta.com · 25/09/2026
NORMAL SITUATION
MEDICETIE
Company — Normal situation.
Financial year 2022 · Closed on 30/09/2022
Net result105,9 k €+1 340,2 %over 1 year
Gross margin-9,3 k €-15,2 %over 1 year
Equity83,6 k €+474,9 %over 1 year
Overview
Identity
Source · BCE/KBOMEDICETIE is a company registered in Belgium.
- Legal situation
- Normal situation
- BCE/KBO no. / VAT
- BE 0878.877.507
- Legal form
- Private company with limited liability
- Contributed capital
- 18 600,00 €
- Latest accounts
- 30/09/2022
Joint committees (1)
- 30502
Signals
ProfitableSolid equityGood liquidityPositive cashflow
Financials
Source · NBB, 16 filingsTrend over 16 financial years
| 2022 | 2021 | 2020 | 2019 | 2018 | |||||
|---|---|---|---|---|---|---|---|---|---|
| Income statement | |||||||||
| Gross margin | -9,3 k € | -15.2% | -8,1 k € | -79.1% | -4,5 k € | +37.5% | -7,2 k € | -581% | -1,1 k € |
| EBITDA | -9,5 k € | -13.0% | -8,4 k € | -82.7% | -4,6 k € | +39.9% | -7,7 k € | -360% | -1,7 k € |
| Operating result | -9,5 k € | -13.0% | -8,4 k € | -82.7% | -4,6 k € | +39.9% | -7,7 k € | -360% | -1,7 k € |
| Net result | 105,9 k € | +1340% | -8,5 k € | -82.7% | -4,7 k € | +87.8% | -38,2 k € | -2066% | -1,8 k € |
| Balance sheet | |||||||||
| Equity | 83,6 k € | +475% | -22,3 k € | -62.1% | -13,8 k € | -51.4% | -9,1 k € | -131% | 29,1 k € |
| Total assets | 118,8 k € | +7204% | 1,6 k € | +1082% | 137,6 € | -87.6% | 1,1 k € | -99.0% | 109,9 k € |
| Cash | 118,8 k € | +7204% | 1,6 k € | +1082% | 137,6 € | -87.6% | 1,1 k € | -99.0% | 109,9 k € |
| Debts | 35,2 k € | +49.0% | 23,6 k € | +74.4% | 13,6 k € | +32.9% | 10,2 k € | -87.4% | 80,8 k € |
Board of directors
Source · NBB, accounts to 30/09/20223 active · 10 ended
Active mandates
Katrien De Meirsman
ActiveStephan Heyman
ActiveSteven Vercauteren
ActiveEnded mandates
Katrien Dr Demeirsman
EndedStephan Dr Heyman
EndedSteven Vercauteren
EndedKatrien De Meirsman
EndedFinancials
Full financial information
Source · NBB| 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | |
|---|---|---|---|---|---|---|
| Type of account | Micro model | Micro model | Micro model | Micro model | Micro model | Micro model |
| Start of the financial year | 01/10/2021 | 01/10/2020 | 01/10/2019 | 01/10/2018 | 01/10/2017 | 01/10/2016 |
| Closing of the financial year | 30/09/2022 | 30/09/2021 | 30/09/2020 | 30/09/2019 | 30/09/2018 | 30/09/2017 |
| Length of the financial year | 12 months | 12 months | 12 months | 12 months | 12 months | 12 months |
| Filing date | 07/04/2023 | 28/04/2022 | 13/04/2021 | 26/03/2020 | 27/02/2019 | 12/03/2018 |
| General meeting | 28/12/2022 | 28/12/2021 | 13/01/2021 | 13/01/2020 | 28/12/2018 | 22/12/2017 |
| Currency of the financial year | EUR | EUR | EUR | EUR | EUR | EUR |
| NBB quality label | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls | Satisfying controls |
Financial ratios
Source · NBBLooking for more information about this company?
Try for 7 daysAnnual accounts filings
Source · NBB, 16 filings| Model | Closing | General meeting | Filed | Language | Document |
|---|---|---|---|---|---|
| Micro model | 30/09/2022 | 28/12/2022 | 07/04/2023 | Dutch | |
| Micro model | 30/09/2021 | 28/12/2021 | 28/04/2022 | Dutch | |
| Micro model | 30/09/2020 | 13/01/2021 | 13/04/2021 | Dutch | |
| Micro model | 30/09/2019 | 13/01/2020 | 26/03/2020 | Dutch | |
| Micro model | 30/09/2018 | 28/12/2018 | 27/02/2019 | Dutch | |
| Micro model | 30/09/2017 | 22/12/2017 | 12/03/2018 | Dutch | |
| Abridged model | 30/09/2016 | 23/12/2016 | 22/03/2017 | Dutch | |
| Abridged model | 30/09/2015 | 28/12/2015 | 02/03/2016 | Dutch | |
| Abridged model | 30/09/2014 | 26/12/2014 | 20/02/2015 | Dutch | |
| Abridged model | 30/09/2013 | 27/12/2013 | 21/03/2014 | Dutch | |
| Abridged model | 30/09/2012 | 28/12/2012 | 11/02/2013 | Dutch | |
| Abridged model | 30/09/2011 | 23/12/2011 | 28/03/2012 | Dutch | |
| Abridged model | 30/09/2010 | 24/12/2010 | 29/03/2011 | Dutch | |
| Abridged model | 30/09/2009 | 24/03/2010 | 28/04/2010 | Dutch | |
| Abridged model | 30/09/2008 | 06/03/2009 | 13/03/2009 | Dutch | |
| Abridged model | 30/09/2007 | 28/12/2007 | 28/01/2008 | Dutch |
Valuation
Indicative valuation
The detail comes with the Business plan: low and high bounds, the valuation bridge for each financial year, transaction multiples by sector and size, group valuation and exports.
Disclaimer
Indicative estimate based on public sector multiples and the filed annual accounts. It is neither a certified valuation nor financial or investment advice.
Directors & structure
Board of directors
Source · NBB, accounts to 30/09/20223 active · 10 ended
Active mandates
Katrien De Meirsman
ActiveStephan Heyman
ActiveSteven Vercauteren
ActiveEnded mandates
Katrien Dr Demeirsman
EndedStephan Dr Heyman
EndedSteven Vercauteren
EndedKatrien De Meirsman
EndedOwnership and network
Looking for more information about this company?
Try for 7 daysPublications
Similar companies
Similar companies
A company's peers, by sector and size, are included in the Business plan.
See the Business planTimeline
Timeline
- 2022Annual accounts 2022105,9 k €↑
- 2021Annual accounts 2021-8,5 k €↓
- 2020Annual accounts 2020-4,7 k €↑
- 2019Annual accounts 2019-38,2 k €↓
- 2018Annual accounts 2018-1,8 k €↑
- 2017Annual accounts 2017-2,9 k €↓
- 2016Annual accounts 2016759,8 €↑
- 2015Annual accounts 2015-6,5 k €↑
- 2014Annual accounts 2014-21 k €↓
- 2013Annual accounts 2013-5,4 k €↑
- 2012Annual accounts 2012-13,8 k €↓
- 2011Annual accounts 2011-12,3 k €↓
- 2010Annual accounts 201064,2 k €↑
- 2009Annual accounts 20094,8 k €↓
- 2008Annual accounts 200816,4 k €↑
- 2007Annual accounts 2007-12,2 k €